Home/Pipeline/Kingdom Therapeutics Collaboration

Kingdom Therapeutics Collaboration

Autism Spectrum Disorder

Pre-clinicalActive

Key Facts

Indication

Autism Spectrum Disorder

Phase

Pre-clinical

Status

Active

Company

Celadon Pharmaceuticals

About Celadon Pharmaceuticals

Celadon Pharmaceuticals is a vertically integrated UK biotech positioned as a leader in developing and manufacturing prescription cannabis-based medicines. The company's core assets include a 100,000 sq ft EU-GMP licensed cultivation and API production facility and a conditionally MHRA-approved Phase 2 clinical trial for chronic pain. Its strategy combines in-house R&D for IP generation with strategic investments, such as in Kingdom Therapeutics for autism spectrum disorder, aiming to build a robust data package for NHS reimbursement and commercial sales.

View full company profile

Therapeutic Areas

Neurology Rare Disease

Other Autism Spectrum Disorder Drugs

Drug	Company	Phase	Status
Autism Program	Ignite Biomedical	Discovery	Active
Banked Cord Blood Stem Cells	Cryo-Cell	Clinical Trials	Investigational